Compare Medipal Holdings Corp. with Similar Stocks
Dashboard
1
Company has very low debt and has enough cash to service the debt requirements
2
Poor long term growth as Net Sales has grown by an annual rate of 3.31% and Operating profit at 6.11% over the last 5 years
3
Flat results in Mar 26
4
With ROE of 8.66%, it has a expensive valuation with a 0.98 Price to Book Value
5
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.85%
0%
-9.85%
6 Months
-6.0%
0%
-6.0%
1 Year
13.24%
0%
13.24%
2 Years
7.65%
0%
7.65%
3 Years
10.06%
0%
10.06%
4 Years
36.53%
0%
36.53%
5 Years
19.89%
0%
19.89%
Medipal Holdings Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.31%
EBIT Growth (5y)
6.11%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
5.93
Tax Ratio
32.84%
Dividend Payout Ratio
32.09%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
14.11%
ROE (avg)
8.85%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.98
EV to EBIT
6.54
EV to EBITDA
4.85
EV to Capital Employed
0.96
EV to Sales
0.09
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.62%
ROE (Latest)
8.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Sep 2018
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
905,687.00
864,156.00
4.81%
Operating Profit (PBDIT) excl Other Income
24,289.00
14,884.00
63.19%
Interest
4.00
2.00
100.00%
Exceptional Items
-10,396.00
-236.00
-4,305.08%
Consolidate Net Profit
7,335.00
6,303.00
16.37%
Operating Profit Margin (Excl OI)
11.00%
11.80%
-0.08%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 4.81% vs 2.41% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 16.37% vs -58.07% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
3,817,354.00
3,671,328.00
3.98%
Operating Profit (PBDIT) excl Other Income
71,834.00
74,028.00
-2.96%
Interest
13.00
7.00
85.71%
Exceptional Items
-15,043.00
-117.00
-12,757.26%
Consolidate Net Profit
53,141.00
51,530.00
3.13%
Operating Profit Margin (Excl OI)
13.90%
15.10%
-0.12%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 3.98% vs 3.16% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 3.13% vs -0.46% in Mar 2025
About Medipal Holdings Corp. 
Medipal Holdings Corp.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






